Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.79
-0.45 (-6.22%)
At close: Aug 14, 2026, 4:00 PM EDT
6.82
+0.03 (0.44%)
After-hours: Aug 14, 2026, 7:59 PM EDT
Ginkgo Bioworks Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -290.8 | -312.76 | -547.03 | -892.87 | -2,105 | -1,830 |
Depreciation & Amortization | 35.33 | 40.29 | 45.02 | 54.81 | 42.55 | 29.08 |
Other Amortization | 18.7 | 18.7 | 18 | 15.7 | - | - |
Loss (Gain) From Sale of Assets | - | - | 7.86 | 43.34 | -28.8 | - |
Asset Writedown & Restructuring Costs | - | - | 78.27 | 130.59 | 1.16 | - |
Loss (Gain) From Sale of Investments | 8.2 | 13.02 | 28.83 | 54.83 | 53.34 | 11.54 |
Loss (Gain) on Equity Investments | 4.67 | - | - | 2.64 | 43.76 | 77.28 |
Stock-Based Compensation | 68.81 | 81.55 | 112.34 | 229.88 | 1,931 | 1,606 |
Other Operating Activities | 17.16 | 32.24 | 26.79 | 35.75 | -152.92 | -86.16 |
Change in Accounts Receivable | -0.2 | -1.47 | -4.73 | 50.07 | 55.02 | -114.09 |
Change in Accounts Payable | -7.31 | -2.99 | 4.77 | -1.18 | -10.84 | -2.25 |
Change in Unearned Revenue | -14.03 | -32.39 | -68.65 | -35.92 | -36.42 | -10.5 |
Change in Other Net Operating Assets | -18.89 | -7.23 | -21.07 | 16.87 | -44.77 | 65.3 |
Operating Cash Flow | -170.24 | -171.06 | -319.59 | -295.5 | -252.2 | -253.82 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -4.56 | -7.67 | -62.54 | -40.8 | -52.27 | -56.52 |
Sale of Property, Plant & Equipment | 0.57 | 0.57 | 0.65 | 4.43 | - | - |
Cash Acquisitions | - | - | -5.4 | - | 74.73 | -12.04 |
Divestitures | - | - | - | -42.98 | -55.72 | - |
Investment in Securities | 60.65 | -233.25 | 4.52 | - | -3.69 | -5 |
Other Investing Activities | -0.16 | 0.05 | 0.54 | -1.34 | -30.44 | 0.3 |
Investing Cash Flow | 56.5 | -240.29 | -62.24 | -80.69 | -67.39 | -73.26 |
Long-Term Debt Repaid | - | -0.35 | -0.9 | -1.3 | -1.24 | -1.12 |
Net Debt Issued (Repaid) | -0.07 | -0.35 | -0.9 | -1.3 | -1.24 | -1.12 |
Issuance of Common Stock | 36.52 | 19.47 | 0.08 | 0.09 | 99.54 | 2,485 |
Repurchase of Common Stock | - | - | - | -0.02 | -0.98 | -901.71 |
Other Financing Activities | -1.9 | -1.34 | -0.93 | -1.99 | -1.99 | -48.19 |
Financing Cash Flow | 34.55 | 17.78 | -1.74 | -3.22 | 95.34 | 1,534 |
Foreign Exchange Rate Adjustments | -0.15 | 0.2 | -0.28 | -0.59 | 0.91 | -0.02 |
Net Cash Flow | -79.34 | -393.37 | -383.84 | -380 | -223.35 | 1,207 |
Free Cash Flow | -174.8 | -178.72 | -382.13 | -336.3 | -304.47 | -310.34 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -132.00% | -105.04% | -168.31% | -133.74% | -63.74% | -98.89% |
Free Cash Flow Per Share | -2.98 | -3.22 | -7.36 | -6.92 | -7.25 | -9.13 |
Levered Free Cash Flow | -72.4 | -72.88 | -238.01 | -119.75 | 596.72 | 444.82 |
Unlevered Free Cash Flow | -72.4 | -72.88 | -237.96 | -119.69 | 596.78 | 446.31 |
Cash Interest Paid | 0 | 0 | 0.03 | 0.08 | 0.09 | 2.37 |
Cash Income Tax Paid | 0.19 | 0.19 | 0.89 | 0.67 | - | 0.06 |
Change in Working Capital | -40.43 | -44.09 | -89.67 | 29.84 | -37.01 | -61.54 |